Fund Holdings — Alphabet Inc.

Total Portfolio Value:
$88.35B
Total Bought:
$11.09B
Total Sold:
$155.14M
Net Transaction:
+$10.94B
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Space Exploration Techn CorpCL A551,189,500555,043,560+3,854,060$94.18B$83.73B94.78%-$10.44B
CME Group Inc.(CME)3,484,0203,484,0200$769.38M$912.74M1.03%+$143.37M
Planet Labs PBCCL A(PL)35,248,89335,248,8930$1.17B$577.73M0.65%-$590.07M
Arm Holdings PlcADS1,960,7841,960,7840$695.24M$567.96M0.64%-$127.27M
Revolution Medicines, Inc.(RVMD)2,946,6192,673,909-272,710$551.84M$548.85M0.62%-$3.00M
QUALCOMM Incorporated(QCOM)02,976,982+2,976,982$0$547.88M0.62%+$547.88M
AST SpaceMobile, Inc.CL A(ASTS)8,943,4868,943,4860$794.72M$526.41M0.60%-$268.30M
Freshworks Inc.CL A(FRSH)16,206,64314,336,643-1,870,000$164.01M$183.37M0.21%+$19.35M
Parabilis Medicines Inc4,919,4984,919,4980$134.65M$158.85M0.18%+$24.20M
Tempus AI, Inc.CL A(TEM)1,551,1021,551,1020$89.86M$127.04M0.14%+$37.18M
UiPath, Inc.CL A(PATH)7,034,3377,034,3370$76.46M$90.32M0.10%+$13.86M
Neutron Holdings Inc01,898,948+1,898,948$0$53.49M0.06%+$53.49M
Prime Medicine, Inc.(PRME)16,562,49816,562,4980$61.12M$50.68M0.06%-$10.43M
PayPay CorporationADS(PAYP)3,125,0003,125,0000$44.78M$49.06M0.06%+$4.28M
Maze Therapeutics, Inc.(MAZE)1,388,5831,388,5830$41.44M$37.74M0.04%-$3.69M
Freenome Inc02,022,131+2,022,131$0$31.85M0.04%+$31.85M
Relay Therapeutics, Inc.(RLAY)1,410,0291,410,0290$26.38M$25.45M0.03%-$930.6K
Fervo Energy CoCL A1,760,7321,760,7320$51.47M$23.93M0.03%-$27.54M
Ethos Technologies Inc.CL A(LIFE)3,622,604571,907-3,050,697$65.71M$19.20M0.02%-$46.52M
Obsidian Therapeutics Inc01,224,869+1,224,869$0$16.82M0.02%+$16.82M
Oscar Health, Inc.CL A(OSCR)481,988481,9880$13.75M$14.86M0.02%+$1.12M
BridgeBio Oncology Therapeutics, Inc.(BBOT)2,823,1262,823,1260$21.51M$11.57M0.01%-$9.94M
Sana Biotechnology, Inc.(SANA)2,812,5002,812,5000$9.82M$8.21M0.01%-$1.60M
Beam Therapeutics Inc.(BEAM)321,604321,6040$11.04M$7.86M0.01%-$3.17M
Vera Therapeutics, Inc.CL A(VERA)241,264241,2640$10.35M$7.79M0.01%-$2.56M
Figma, Inc.CL A(FIG)215,582215,5820$3.90M$4.53M0.01%+$631.7K
Monte Rosa Therapeutics, Inc.(GLUE)372,474372,4740$9.01M$4.44M0.01%-$4.57M
Lyell Immunopharma, Inc.(LYEL)293,256293,2560$4.12M$2.87M0.00%-$1.25M
Hyperfine, Inc.CL A(HYPR)898,720898,7200$1.21M$728.0K0.00%-$485.3K
Autolus Therapeutics plcADS(AUTL)698,2620-698,262$1.12M$0—-$1.12M
GitLab Inc.CL A(GTLB)2,724,7120-2,724,712$83.19M$0—-$83.19M
Spero Therapeutics, Inc.(SPRO)889,9790-889,979$1.97M$0—-$1.97M
Page 1 of 1
Alphabet Inc. — 13F Holdings — Q3 2026 | TickerTrail